… So Yeon Park … So Yeon Park is currently a postdoctoral researcher in the Chemistry
and Nanoscience Center at National Renewable Energy Laboratory. She received a Ph.D. …

Human epidermal growth factor receptor 2 (HER2) protein overexpression and/or HER2
gene amplification is found in about 20% of invasive breast cancers. It is a sole predictive …

Recurrent cancer that spreads to distant sites is the leading cause of disease-related death
among cancer patients. Cancer cells are likely to disseminate during cancer progression, …

Intratumor heterogeneity is a major clinical problem because tumor cell subtypes display
variable sensitivity to therapeutics and may play different roles in progression. We previously …

The performance of three-dimensional (3D) organic-inorganic halide perovskite solar cells (PSCs)
can be enhanced through surface treatment with 2D layered perovskites that have …

The reality of multi-core hardware has made concurrent programs pervasive. Unfortunately,
writing correct concurrent programs is difficult. Addressing this challenge requires advances …

Purpose: To evaluate the expression of stem cell–related markers at the cellular level in
human breast tumors of different subtypes and histologic stage. Experimental Design: We …

Intratumor genetic heterogeneity is a key mechanism underlying tumor progression and
therapeutic resistance. The prevailing model for explaining intratumor diversity, the clonal …

Intratumoral heterogeneity of human epidermal growth factor receptor 2 (HER2) gene
amplification has been reported to occur with variable frequencies in breast cancers. However, …

The 20S proteasome functions in protein degradation in eukaryotes together with the 19S
ATPases or in archaea with the homologous PAN ATPase complex. These ATPases contain a …